We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+0.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.1B
AUM Growth
-$409M
Cap. Flow
-$686M
Cap. Flow %
-2.74%
Top 10 Hldgs %
12.48%
Holding
1,468
New
129
Increased
446
Reduced
556
Closed
107

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$136M
2
WP
Worldpay, Inc.
WP
+$129M
3
BIDU icon
Baidu
BIDU
+$82.5M
4
AMZN icon
Amazon
AMZN
+$77M
5
PH icon
Parker-Hannifin
PH
+$71.3M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$82.7M
2
PFE icon
Pfizer
PFE
+$78.2M
3
INTC icon
Intel
INTC
+$75.2M
4
HPE icon
Hewlett Packard
HPE
+$66.7M
5
AMGN icon
Amgen
AMGN
+$65.9M

Sector Composition

Rank Sector Weight
1 Technology 21.85%
2 Healthcare 15.95%
3 Financials 11.47%
4 Consumer Discretionary 11.41%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNDX icon
651
Vanguard Total International Bond ETF
BNDX
$82.7B
$4.54M 0.02%
83,010
+4,070
+5% +$221K
TNET icon
652
TriNet
TNET
$3.17B
$4.53M 0.02%
97,700
+91,900
+1,584% +$4.06M
MLNX
653
DELISTED
Mellanox Technologies, Ltd.
MLNX
$4.52M 0.02%
62,000
ENVA icon
654
Enova International
ENVA
$4.32B
$4.5M 0.02%
204,200
+98,500
+93% +$1.98M
HY icon
655
Hyster-Yale Materials Handling
HY
$609M
$4.49M 0.02%
64,269
-400
-0.6% -$31.6K
ADMS
656
DELISTED
Adamas Pharmaceuticals
ADMS
$4.46M 0.02%
+186,793
New +$5.89M
CHRS icon
657
Coherus Oncology
CHRS
$198M
$4.46M 0.02%
403,680
-3,974
-1% -$43.5K
LGIH icon
658
LGI Homes
LGIH
$1.19B
$4.45M 0.02%
63,100
-34,500
-35% -$2.33M
WAT icon
659
Waters Corp
WAT
$41.4B
$4.45M 0.02%
22,408
-7,900
-26% -$1.63M
ZD icon
660
Ziff Davis
ZD
$2.05B
$4.45M 0.02%
64,860
-40,020
-38% -$2.71M
SRPT icon
661
Sarepta Therapeutics
SRPT
$2.14B
$4.42M 0.02%
+59,593
New +$3.97M
AA icon
662
Alcoa
AA
$12.5B
$4.38M 0.02%
97,500
-36,199
-27% -$1.79M
SMMT icon
663
Summit Therapeutics
SMMT
$14B
$4.36M 0.02%
338,000
+55,240
+20% +$690K
CLGX
664
DELISTED
Corelogic, Inc.
CLGX
$4.36M 0.02%
96,351
+6,300
+7% +$290K
BLUE
665
DELISTED
bluebird bio
BLUE
$4.35M 0.02%
1,969
+47
+2% +$120K
CLDT
666
Chatham Lodging
CLDT
$607M
$4.31M 0.02%
225,000
FNV icon
667
Franco-Nevada
FNV
$50.8B
$4.3M 0.02%
62,907
+16,388
+35% +$1.2M
MFC icon
668
Manulife Financial
MFC
$73.2B
$4.29M 0.02%
230,979
+19,100
+9% +$382K
CACC icon
669
Credit Acceptance
CACC
$6.31B
$4.26M 0.02%
+12,900
New +$4.27M
ACHN
670
DELISTED
Achillion Pharmaceuticals
ACHN
$4.26M 0.02%
1,147,834
-11,721
-1% -$38.4K
WEB
671
DELISTED
Web.com Group, Inc.
WEB
$4.25M 0.02%
234,800
EWQ icon
672
iShares MSCI France ETF
EWQ
$347M
$4.2M 0.02%
133,767
AON icon
673
Aon
AON
$64B
$4.18M 0.02%
29,778
-33,020
-53% -$4.62M
CRUS icon
674
Cirrus Logic
CRUS
$5.97B
$4.17M 0.02%
102,720
+19,600
+24% +$910K
KFRC icon
675
Kforce
KFRC
$927M
$4.12M 0.02%
152,431
+36,900
+32% +$992K

Similar funds

Axa's Q1 2018 Portfolio in Review

As of Q1 2018, Axa held 1,468 positions worth $25.1B, down 1.6% from $25.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q1 2018 filing shows 129 new, 446 increased, 556 reduced and 107 closed positions. Its largest new stake was Invesco: 793,817 shares worth $25.4M. The largest sale was AT&T, an estimated $82.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q1 2018 buy was Invesco: 793,817 shares worth $25.4M.
  • Axa added most to Alibaba in Q1 2018, an estimated $136M increase.
  • Axa's biggest Q1 2018 reduction was AT&T, cutting an estimated $82.7M.
  • Axa fully exited DST Systems Inc. in Q1 2018, selling an estimated $23.6M.
  • Axa's ten largest holdings make up 12% of its $25.1B portfolio in Q1 2018.
  • Axa opened 129 new positions and closed 107 in Q1 2018.
  • Axa's portfolio value fell 1.6% quarter-over-quarter to $25.1B.

Based on Axa's 13F filing for Q1 2018, filed 14 May 2018.